Navigation Links
Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe
Date:3/10/2009

CAMBRIDGE, Mass., March 10 /PRNewswire/ -- Tolerx, Inc., today announced that DEFEND (Durable Response Therapy Evaluation For Early or New Onset Type 1 Diabetes), the Phase 3 trial of otelixizumab, an investigational novel targeted immunotherapeutic, has begun enrollment of new onset autoimmune type 1 diabetes patients in Europe. In DEFEND, preserving beta cell function subsequent to the administration of otelixizumab is the primary outcome that is being evaluated. This outcome will be assessed by measuring C-peptide levels (a surrogate of endogenous insulin secretion) and by measuring reductions in the amount of injected insulin used to maintain excellent glycemic control.

DEFEND continues to actively recruit subjects in the United States, Canada, Sweden, Finland, Germany, Italy, and the UK. Tolerx anticipates that enrollment will soon commence at clinical sites in Spain and Denmark.

"Our participation in DEFEND reflects our research priorities to support the development of innovative immune intervention for type 1 diabetes patients. We have begun dosing otelixizumab in DEFEND and are excited about its potential to be an effective treatment option for type 1 diabetics," stated Dr. Paolo Pozzilli, Professor University Campus Bio-Medico, Rome Italy.

"We are pleased that an increasing number of excellent clinical researchers in Europe and North America have started DEFEND at their sites and look forward to their continued participation in this important effort. We believe that a single short course of otelixizumab may have the potential to preserve residual beta cell function and offer people with autoimmune type 1 diabetes improved disease control" said Dr. Louis Vaickus, Chief Medical Officer of Tolerx. He continued "We are seeking in DEFEND to conclusively demonstrate this understanding."

About the DEFEND Study

DEFEND is a
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Tolerx Named as One of the Fierce 15 Biotech Companies of 2008
2. Laureate Announces Manufacturing Agreement with Tolerx
3. ATS Medical Expands Open Pivot Heart Valve Offerings
4. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
5. BioLife Solutions Expands Scientific Advisory Board
6. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
7. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
8. Pharsight Expands Strategic Consulting Services Team
9. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
10. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
11. AQUISS Expands Into Significant New Territory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Cynvenio, a cancer diagnostics company focused on ... of tumor cells in the bloodstream, today announced that ... support application powered by CollabRx, Inc. , Available ... Therapy Finder will provide breast cancer patients and their ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 This webinar ... nonclinical and clinical safety assessment in biosimilars. , Regulatory ... for biosimilar drug development, however the complex nature of ... quality, safety and efficacy extremely challenging. Based on the ...
(Date:1/15/2014)... Two champions of science, technology, engineering, ... an annual competition for middle and high school students ... STEM study. The competition presents students with real-world problems ... Aptitude, Mathematics, and Sciences is a program administered ...
(Date:1/15/2014)... Arizona (PRWEB) January 15, 2014 2013 ... for Scottsdale’s Brain State Technologies®. They saw continued independent ... Medical Center who were awarded a $1 million grant ... published in “Brain and Behavior” a peer reviewed journal, ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... prospect of electronics at the nanoscale may be ... metallic conductance in ferroelectric nanodomains by researchers at ... switch their polarization with the application of an ... such as ultrasound machines and sensors. Now, discoveries ...
... SOUTHBRIDGE, Mass., Jan. 9, 2012 INCOM Inc., the ... today announced that it has acquired Paradigm Optics, a ... Washington.  The acquisition includes all intellectual property related to ... as all physical assets and capital equipment.  Paradigm Optics ...
... Exagen Diagnostics, Inc., a specialty focused molecular ... for rheumatologists and gastroenterologists, announced today the launch of ... (Systemic Lupus Erythematosus). Avise SLE is a ... rheumatic diseases to help establish the most accurate SLE ...
Cached Biology Technology:ORNL experiments prove nanoscale metallic conductivity in ferroelectrics 2INCOM Inc. Announces Acquisition of Paradigm Optics 2Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic 2
(Date:4/23/2014)... ripping open a dinner roll, a fuel cell catalyst ... hydrogen molecule. Now researchers have captured a view of ... its hydrogen feast. The view confirms previous hypotheses and ... better for alternative energy uses. , This study is ... hydrogen halves end up in the structure of a ...
(Date:4/23/2014)... A team of researchers in Korea ... the brains of nonhuman primates and assessed cell ... found that the hNSCs had differentiated into neurons ... , The study will be published in a ... is currently freely available on-line as an unedited ...
(Date:4/23/2014)... Researchers have found evidence of an interaction between ... aggressive behavior in children, especially in girls. , ... exposed to prenatal smoking will have behavioral problems. ... Brian Boutwell, Assistant Professor at Sam Houston State ... on the study. "One possible explanation for ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Study finds long-term survival of human neural stem cells transplanted into primate brain 2Genetics risk, prenatal smoking may predict behavioral problems 2
... role in rehabilitating goats and other animals that have suffered ... London. In this first scientific study of rescued ... which had endured poor welfare, such as inappropriate diet, and ... They created a spatial awareness test, which involved giving the ...
... [Boston, MA] The scientific poster session, Interventions for the ... poster that won first prize in two American ... contests the Student Interest Group (SIG) Travel Award competition ... (RIS) Graduate Student Poster competition. The winning poster is ...
... & Science University (OHSU) and Intel Corp. are ... advance the field of personalized medicine by dramatically ... a patient,s individual genetic profile. Through a multi-year ... scientists from the two institutions will develop hardware, ...
Cached Biology News:Rescue me: New study finds animals do recover from neglect 2Penn State Hass avocado research poster wins American Society For Nutrition Annual Awards 2OHSU teams with Intel to decode the root causes of cancer and other complex diseases 2OHSU teams with Intel to decode the root causes of cancer and other complex diseases 3OHSU teams with Intel to decode the root causes of cancer and other complex diseases 4OHSU teams with Intel to decode the root causes of cancer and other complex diseases 5
5-bromo-2'-deoxyuridine (BrdU) Cell Biology Cell Proliferation Bromodeoxyuridine (BrdU) and Related Products...
2'-Fluorine-CTP (2'-F-CTP) is readily incorporated into transcripts by T7 and SP6 R&DNA™ Polymerase and is available separately....
... This volume provides excellent background information, detailed ... of major HIV proteins including: the HIV ... and protease. Expression of HIV proteins using ... assays; HIV/CD4 interactions; transient assays for Nef-induced ...
Human Glypican 2 Biotinylated Affinity Purified PAb...
Biology Products: